Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data

Tabrizi, SJ; Reilmann, R; Roos, RAC; Durr, A; Leavitt, B; Owen, G; Jones, R; Johnson, H; Craufurd, D; Hicks, SL; +8 more... Kennard, C; Landwehrmeyer, B; Stout, JC; Borowsky, B; Scahill, RI; Frost, C; Langbehn, DR; Investigators, T.-, H; (2012) Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Lancet neurology, 11 (1). pp. 42-53. ISSN 1474-4422 DOI: https://doi.org/10.1016/S1474-4422(11)70263-0

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S1474-4422(11)70263-0

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar